首页> 外文期刊>Molecular medicine reports >Adrenomedullin improves intestinal epithelial barrier function by downregulating myosin light chain phosphorylation in ulcerative colitis rats
【24h】

Adrenomedullin improves intestinal epithelial barrier function by downregulating myosin light chain phosphorylation in ulcerative colitis rats

机译:肾上腺髓质素通过下调溃疡性结肠炎大鼠中的肌球蛋白轻链磷酸化改善肠道上皮屏障功能

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Adrenomedullin (AM) is a pivotal endogenous vasoactive peptide, which can maintain epithelial barrier function in inflammatory bowel disease. Myosin light chain kinase (MLCK)-dependent phosphorylated myosin light chain kinase (p-MLC) is a key regulator of intestinal barrier function. The aim of the present study was to investigate the effect and mechanism of AM on the intestinal epithelial barrier in a rat model of ulcerative colitis (UC) induced by 2,4,6-trinitro-benzene-sulfonic acid (TNBS). A total of 21 male Sprague-Dawley rats were randomly divided into the following three groups and administered different agents for 7 days: The normal group (water and saline), model group (TNBS and saline) and the AM group (TNBS and AM; 1.0 mu g). The weight of rats was recorded every day. Serum tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) levels were detected using ELISA kits. Colon tissue was collected for the assessment of histological alterations. The protein expression of MLCK, p-MLC and zonula occludens-1 (ZO-1) was examined by western blot analysis. Intestinal epithelial tight junctions were examined using transmission electron microscopy. The results demonstrated that in colitis model rats, the expression of TNF-a, IL-6, MLCK and p-MLC significantly increased compared with normal rats. In addition, the expression of ZO-1 decreased (P< 0.05) and intestinal epithelial cell permeability increased. Following AM administration, TNF-a, IL-6, MLCK and p-MLC expression significantly decreased compared with the model rats, the expression of ZO-1 increased (P< 0.05) and intestinal epithelial cell permeability reduced. These data indicate a protective effect of AM on intestinal epithelial barrier dysfunction via suppression of inflammatory cytokines and downregulation of MLCK-p-MLC in TNBS-induced UC. In conclusion, AM/MLCK-p-MLC may be an important signaling pathway in the occurrence and development of UC.
机译:肾上腺髓质素(AM)是一种关键的内源性血管活性肽,在炎性肠病中可以维持上皮屏障功能。肌球蛋白轻链激酶(MLCK)依赖性磷酸化的肌球蛋白轻链激酶(p-MLC)是肠屏障功能的关键调节剂。本研究的目的是研究AM对2,4,6-三硝基苯磺酸(TNBS)诱发的溃疡性结肠炎(UC)大鼠模型中肠上皮屏障的作用和机制。将总共​​21只雄性Sprague-Dawley大鼠随机分为以下三组,并给予不同的药物治疗7天:正常组(水和盐水),模型组(TNBS和盐水)和AM组(TNBS和AM); 1.0微克)。每天记录大鼠的体重。使用ELISA试剂盒检测血清肿瘤坏死因子-α(TNF-α)和白介素6(IL-6)的水平。收集结肠组织用于评估组织学改变。通过蛋白质印迹分析检查了MLCK,p-MLC和小带闭合蛋白-1(ZO-1)的蛋白表达。使用透射电子显微镜检查肠上皮紧密连接。结果表明,在结肠炎模型大鼠中,与正常大鼠相比,TNF-α,IL-6,MLCK和p-MLC的表达显着增加。此外,ZO-1的表达降低(P <0.05),肠上皮细胞通透性增加。 AM给药后,与模型大鼠相比,TNF-α,IL-6,MLCK和p-MLC的表达显着降低,ZO-1的表达增加(P <0.05),肠上皮细胞的通透性降低。这些数据表明AM通过抑制炎症细胞因子和下调TNBS诱导的UC中的MLCK-p-MLC而对肠道上皮屏障功能障碍的保护作用。总之,AM / MLCK-p-MLC可能是UC发生和发展的重要信号通路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号